Cross-Linking and Lipid Efflux Properties of ApoA-I Mutants Suggest Direct Association between ApoA-I Helices and ABCA1

Biochemistry

Volumn 43, Issue 7, 2004, Pages 2126-2139

  Chroni, Angeliki ^a   Liu, Tong ^a   Fitzgerald, Michael L ^b   Freeman, Mason W ^b   Zannis, Vassilis I ^a  

^a BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ASSOCIATION REACTIONS; CHOLESTEROL; CROSSLINKING; LIPIDS;

BIOGENESIS; MUTATIONS;

BIOCHEMISTRY;

ABC TRANSPORTER A1; APOLIPOPROTEIN A1; CELL PROTEIN; LIPID; MUTANT PROTEIN; UNCLASSIFIED DRUG;

AMINO ACID SEQUENCE; AMINO TERMINAL SEQUENCE; ARTICLE; CARBOXY TERMINAL SEQUENCE; CHOLESTEROL TRANSPORT; HUMAN; HUMAN CELL; MOLECULAR DYNAMICS; NONHUMAN; PRIORITY JOURNAL; PROTEIN CROSS LINKING; PROTEIN DOMAIN; PROTEIN PROTEIN INTERACTION;

AMINO ACID SUBSTITUTION; ANIMALS; APOLIPOPROTEIN A-I; ATP-BINDING CASSETTE TRANSPORTERS; BINDING, COMPETITIVE; BIOLOGICAL TRANSPORT; CELL LINE; CELL LINE, TUMOR; CHOLESTEROL, HDL; HUMANS; MICE; MODELS, CHEMICAL; MUTAGENESIS; PEPTIDE FRAGMENTS; PROTEIN ISOFORMS; PROTEIN STRUCTURE, SECONDARY; SEQUENCE DELETION; SERINE; TRYPTOPHAN;

EID: 1242285439     PISSN: 00062960     EISSN: None     Source Type: Journal    
DOI: 10.1021/bi035813p     Document Type: Article

References (57)

1. Zannis, V. I., Kardassis, D., and Zanni, E. E. (1993) Genetic Mutations Affecting Human Lipoproteins, Their Receptors, and Their Enzymes, Adv. Hum. Genet. 217, 145-379.
2. von Eckardstein, A., Nofer, J. R., and Assmann, G. (2001) High-density lipoproteins and arteriosclerosis. Role of cholesterol efflux and reverse cholesterol transport, Arterioscler. Thromb. Vasc. Biol. 21. 13-27.
3. Gagescu, R., Demaurex, N., Parton, R. G., Hunziker, W., Huber, L. A., and Gruenberg, J. (2000) The recycling endosome of Madin-Darby canine kidney cells is a mildly acidic compartment rich in raft components, Mol. Biol. Cell 11, 2775-2791.
4. Fielding, C. J. (2001) Caveolae and signaling, Curr. Opin. Lipidol. 12. 281-287.
5. Lawn, R. M., Wade, D. P., Garvin, M. R., Wang, X., Schwartz, K., Porter. J. G., Seilhamer, J. J., Vaughan, A. M., and Oram, J. F. (1999) The Tangier disease gene product ABC1 controls the cellular apolipoprotein-mediated lipid removal pathway, J. Clin. Invest. 104, R25-R31.
6. Brooks-Wilson, A., Marcil, M., Clee, S. M., Zhang, L. H., Roomp, K., van Dam, M., Yu, L., Brewer, C., Collins, J. A., Molhuizen, H. O. F., Loubser, O., Ouelette, B. F. F., Fichter, K., Ashbourne-Excoffon, K. J. D., Sensen, C. W., Scherer, S., Mott, S., Denis, M., Martindale, D., Frohlich, J., Morgan, K., Koop, B., Pimstone, S., Kastelein, J. J. P., Genest, J., Jr., and Hayden, M. R. (1999) Mutations in ABC1 in Tangier disease and familial high-density lipoprotein deficiency, Nat. Genet. 22, 336-345.
7. Bodzioch, M., Orso, E., Klucken, J., Langmann, T., Bottcher, A., Diederich, W., Drobnik, W., Barlage, S., Buchler, C., Porsch-Ozcurumez, M., Kaminski, W. E., Hahmann, H. W., Oette, K., Rothe, G., Aslanidis, C., Lackner, K. J., and Schmitz, G. (1999) The gene encoding ATP-binding cassette transporter 1 is mutated in Tangier disease, Nat. Genet. 22, 347-351.
8. Rust, S., Rosier, M., Funke, H., Real, J., Amoura, Z., Piette, J. C., Deleuze, J. F., Brewer, H. B., Duverger, N., Denefle, P., and Assmann, G. (1999) Tangier disease is caused by mutations in the gene encoding ATP-binding cassette transporter 1, Nat. Gener. 22, 352-355.
9. Oram, J. F., Lawn, R. M., Garvin, M. R., and Wade, D. P. (2000) ABCAI is the cAMP-inducible apolipoprotein receptor that mediates cholesterol secretion from macrophages, J. Biol. Chem. 275, 34508-34511.
10. Wang, N., Silver, D. L., Thiele, C., and Tall, A. R. (2001) ATP-binding cassette transporter AI (ABCA1) functions as a cholesterol efflux regulatory protein, J. Biol. Chem. 276, 23742-23747.
11. Chambenoit, O., Hamon, Y., Marguet, D., Rigneault, H., Rosseneu, M., and Chimini, G. (2001) Specific docking of apolipoprotein A-I at the cell surface requires a functional ABCA1 transporter, J. Biol. Chem. 276, 9955-9960.
12. Rigot. V., Hamon, Y., Chambenoit, O., Alibert. M., Duverger, N., and Chimini, G. (2002) Distinct sites on ABCA1 control distinct steps required for cellular release of phospholipids, J. Lipid Res. 43, 2077-2086.
13. Fielding, P. E., Nagao, K., Hakamata, H., Chimini, G., and Fielding, C. J. (2000) A two-step mechanism for free cholesterol and phospholipid efflux from human vascular cells to apolipo-protein A-I, Biochemistry 39, 14113-14120.
14. Forte, T. M., Goth-Goldstein, R., Nordhausen, R. W., and McCall, M. R. (1993) Apolipoprotein A-I-cell membrane interaction: extracellular assembly of heterogeneous nascent HDL particles, J. Lipid Res. 34, 317-324.
15. Forte. T. M., Bielicki, J. K., Goth-Goldstein, R., Selmek. J., and McCall, M. R. (1995) Recruitment of cell phospholipids and cholesterol by apolipoproteins A-II and A-I: formation of nascent apolipoprotein-specific HDL that differ in size, phospholipid composition, and reactivity with LCAT, J. Lipid Res. 36, 148-157.
16. Fielding, C. J., and Fielding, P. E. (1995) Molecular physiology of reverse cholesterol transport, J. Lipid Res. 36, 211-228.
17. Castro, G. R., and Fielding, C. J. (1988) Early incorporation of cell-derived cholesterol into pre-beta-migrating high-density lipoprotein, Biochemistry 27, 25-29.
18. Vaughan, A. M., and Oram, J. F. (2003) ABCA1 redistributes membrane cholesterol independent of apolipoprotein interactions, J. Lipid Res. 44, 1373-1380.
19. Panagotopulos, S. E., Witting, S. R., Horace. E. M., Hui, D. Y., Maiorano, J. N., and Davidson, W. S. (2002) The role of apolipoprotein A-I helix 10 in apolipoprotein-mediated cholesterol efflux via the ATP-binding cassette transporter ABCA1, J. Biol. Chem. 277, 39477-39484.
20. Fitzgerald, M. L., Morris, A. L., Rhee, J. S., Andersson, L. P., Mendez, A. J., and Freeman, M. W. (2002) Naturally Occurring Mutations in the Largest Extracellular Loops of ABCA1 Can Disrupt Its Direct Interaction with Apolipoprotein A-I, J. Biol. Chem. 277, 33178-33187.
21. Chroni, A., Liu, T., Gorshkova, I., Kan, H. Y., Uehara, Y., von Eckardstein, A., and Zannis, V. I. (2003) The Central Helices of ApoA-I Can Promote ATP-binding Cassette Transporter AI (ABCA1)-mediated Lipid Efflux. Amino Acid Residues 220-231 of the Wild-Type ApoA-I are Required for Lipid Efflux in vitro and High-Density Lipoprotein Formation in vivo, J. Biol. Chem. 278, 6719-6730.
22. Gorshkova, I. N., Liu, T., Zannis, V. I., and Atkinson, D. (2002) Lipid-free structure and stability of apolipoprotein A-I: Probing the central region by mutation, Biochemistry 41, 10529-10539.
23. Liadaki, K. N., Liu, T., Xu, S., Ishida, B. Y., Duchateaux, P. N., Krieger, J. P., Kane, J., Krieger, M., and Zannis, V. I. (2000) Binding of High-Density Lipoprotein (HDL) and Discoidal Reconstituted HDL to the HDL Receptor Scavenger Receptor Class B Type I. Effect of Lipid Association and ApoA-I Mutations on Receptor Binding, J. Biol. Chem. 275, 21262-21271.
24. Liu, T., Krieger, M., Kan, H. Y., and Zannis, V. I. (2002) The Effects of Mutations in Helices 4 and 6 of ApoA-I on Scavenger Receptor Class B Type I (SR-BI)-mediated Cholesterol Efflux Suggest That Formation of a Productive Complex between Reconstituted High-Density Lipoprotein and SR-BI Is Required for Efficient Lipid Transport, J. Biol. Chem. 277, 21576-21584.
25. Luckow, V. A., Lee, S. C., Barry, G. F., and Olins, P. O. (1993) Efficient Generation of Infectious Recombinant Baculoviruses by Site-Specific Transposon-Mediated Insertion of Foreign Genes Into A Baculovirus Genome Propagated in Escherichia-Coli, J. Virol. 67, 4566-4579.
26. Anderson, D., Harris, R., Polayes, D., Ciccarone, V., Donahue, R., Gerard, G., Haces, A., Whitford. W., Bloom. F., Luckow, V., and Jessee. J. (1995) Rapid Generation of Recombinant Baculovirus and Expression of Foreign Genes Using the Bac-To-Bac-(Tm) Expression System, FASEB J. 9, A1464.
27. Sorci-Thomas, M. G., Parks, J. S., Kearns, M. W., Pate, G. N., Zhang, C., and Thomas, M. J. (1996) High level secretion of wildtype and mutant forms of human proapoA-I using baculovirus-mediated Sf-9 cell expression. J. Lipid Res. 37, 673-683.
28. Crowe, J., Masone, B. S., and Ribbe, J. (1995) One-step purification of recombinant proteins with the 6xHis tag and Ni-NTA resin, Mol. Biotechnol. 4, 247-258.
29. Crowe, J., Masone, B. S., and Ribbe, J. (1996) One-step purification of recombinant proteins with the 6xHis tag and Ni-NTA resin, Methods Mol. Biol. 58, 491-510.
30. Gorshkova, I. N., Liadaki, K., Gursky, O., Atkinson, D., and Zannis, V. I. (2000) Probing the lipid-free structure and stability of apolipoprotein A-I by mutation, Biochemistry 39. 15910-15919.
31. Reardon, C. A., Kan, H. Y., Cabana, V., Blachowicz, L., Lukens, J. R., Wu, Q. Z., Liadaki, K., Getz, G. S., and Zannis, V. I. (2001) In vivo studies of HDL assembly and metabolism using adenovirus-mediated transfer of apoA-I mutants in apoA-I-deficient mice, Biochemistry 40, 13670-13680.
32. Laccotripe, M., Makrides, S. C., Jonas, A., and Zannis, V. I. (1997) The carboxyl-terminal hydrophobic residues of apolipoprotein A-I affect its rate of phospholipid binding and its association with high-density lipoprotein, J. Biol. Chem. 272, 17511-17522.
33. Markwell, M. A. (1982) A new solid-state reagent to iodinate proteins. I. Conditions for the efficient labeling of antiserum, Anal. Biochem. 125, 427-432.
34. Li, X. P., Kan, H. Y., Lavrentiadou, S., Krieger, M., and Zannis, V. (2002) Reconstituted discoidal ApoE-phospholipid particles are ligands for the scavenger receptor BI-The amino-terminal 1-165 domain of ApoE suffices for receptor binding, J. Biol. Chem. 277, 21149-21157.
35. Fitzgerald. M. L., Mendez, A. J., Moore, K. J., Andersson, L. P., Panjeton, H. A., and Freeman, M. W. (2001) ATP-binding Cassette Transporter AI Contains an NH2-terminal Signal Anchor Sequence That Translocates the Protein's First Hydrophilic Domain to the Exoplasmic Space, J. Biol. Chem. 276, 15137-15145.
36. Bligh, E. G., and Dyer, W. J. (1959) Can. J. Biochem. Physiol. 37, 911-918.
37. Nolte, R. T., and Atkinson, D. (1992) Conformational analysis of apolipoprotein A-I and E-3 based on primary sequence and circular dichroism, Biophys. J. 63, 1221-1239.
38. Borhani, D. W., Rogers, D. P., Engler, J. A., and Brouillette, C. G. (1997) Crystal structure of truncated human apolipoprotein A-I suggests a lipid-bound conformation, Proc. Natl. Acad. Sci. U.S.A. 94, 12291-12296.
39. Miccoli, R., Zhu, Y., Daum, U., Wessling, J., Huang, Y., Navalesi, R., Assmann, G., and von Eckardstein, A. (1997) A natural apolipoprotein A-I variant, apoA-I (L141R)Pisa, interferes with the formation of alpha-high-density lipoproteins (HDL) but not with the formation of pre beta I-HDL and influences efflux of cholesterol into plasma, J. Lipid Res. 38, 1242-1253.
40. Miccoli, R., Bertolotto, A., Navalesi, R., Odoguardi, L., Boni, A., Wessling, J., Funke, H., Wiebusch, H., von Eckardstein. A., and Assmann, G. (1996) Compound Heterozygosity for a Structural Apolipoprotein A-I Variant, Apo A-I(L141R)Pisa, and an Apolipoprotein A-I Null Allele in Patients With Absence of HDL Cholesterol, Corneal Opacifications, and Coronary Heart Disease, Circulation 94, 1622-1628.
41. Lapicka-Bodzioch, K., Bodzioch, M., Krull, M., Kielar, D., Probst, M., Kiec, B., Andrikovics, H., Bottcher, A., Hubacek, J., Aslanidis, C., Suttorp, N., and Schmitz, G. (2001) Homogeneous assay based on 52 primer sets to scan for mutations of the ABCA1 gene and its application in genetic analysis of a new patient with familial high-density lipoprotein deficiency syndrome, Biochim. Biophys. Acta 1537, 42-48.
42. Matsunaga, T., Hiasa, Y., Yanagi, H., Maeda, T., Hattori, N., Yamakawa, K., Yamanouchi, Y., Tanaka, I., Obara, T., and Hamaguchi, H. (1991) Apolipoprotein A-I deficiency due to a codon 84 nonsense mutation of the apolipoprotein A-I gene, Proc. Natl. Acad. Sci. U.S.A. 88, 2793-2797.
43. McNeish, J., Aiello, R. J., Guyot, D., Turi, T., Gabel, C., Aldinger, C., Hoppe, K. L., Roach, M. L., Royer, L. J., de Wet, J., Broccardo, C., Chimini, G., and Francone, O. L. (2000) High-density lipoprotein deficiency and foam cell accumulation in mice with targeted disruption of ATP-binding cassette transporter-1, Proc. Natl. Acad. Sci. U.S.A. 97, 4245-4250.
44. Williamson, R., Lee, D., Hagaman, J., and Maeda, N. (1992) Marked reduction of high density lipoprotein cholesterol in mice genetically modified to lack apolipoprotein A-I, Proc. Natl. Acad. Sci. U.S.A. 89, 7134-7138.
45. Wang, N., Silver, D. L., Costet, P., and Tall, A. R. (2000) Specific binding of ApoA-I, enhanced cholesterol efflux, and altered plasma membrane morphology in cells expressing ABC 1, J. Biol. Chem. 275, 33053-33058.
46. Wilson, C., Wardell, M. R., Weisgraber, K. H., Mahley, R. W., and Agard, D. A. (1991) Three-dimensional structure of the LDL receptor-binding domain of human apolipoprotein E, Science 252, 1817-1822.
47. Remaley, A. T., Stonik, J. A., Demosky, S. J., Neufeld, E. B., Bocharov, A. V., Vishnyakova, T. G., Eggerman, T. L., Patterson, A. P., Duverger, N. J., Santamarina-Fojo, S., and Brewer, H. B., Jr. (2001) Apolipoprotein specificity for lipid efflux by the human ABCA1 transporter, Biochem. Biophys. Res. Commun. 280, 818-823.
48. Remaley, A. T., Thomas, F., Stonik, J. A., Demosky, S. J., Bark, S. E., Neufeld, E. B., Bocharov, A. V., Vishnyakova, T. G., Patterson, A. P., Eggerman, T. L., Santamarina-Fojo, S., and Brewer, H. B. (2003) Synthetic amphipathic helical peptides promote lipid efflux from cells by an ABCA1-dependent and an ABCA1-independent pathway, J. Lipid Res. 44, 828-836.
49. Fitzgerald, M. L., Morris, A. L., Chroni, A., Mendez, A. J., Zannis, V. I., and Freeman, M. W. (2003) ABCA1 and amphipathic apolipoproteins form high affinity molecular complexes required for cholesterol efflux, J. Lipid Res., in press.
50. Borghini, I., Barja, F., Pometta, D., and James, R. W. (1995) Characterization of subpopulations of lipoprotein particles isolated from human cerebrospinal fluid. Biochim. Biophys. Acta 1255, 192-200.
51. Pitas. R. E., Boyles, J. K., Lee, S. H., Hui, D., and Weisgraber, K. H. (1987) Lipoproteins and their receptors in the central nervous system. Characterization of the lipoproteins in cerebrospinal fluid and identification of apolipoprotein B, E(LDL) receptors in the brain, J. Biol. Chem. 262, 14352-14360.
52. Huang, Y., von Eckardstein, A., Wu, S., Maeda, N., and Assmann, G. (1994) A plasma lipoprotein containing only apolipoprotein E and with gamma mobility on electrophoresis releases cholesterol from cells, Proc. Natl. Acad. Sci. U.S.A. 91, 1834-1838.
53. Boyles, J. K., Pitas, R. E., Wilson, E., Mahley, R. W., and Taylor, J. M. (1985) Apolipoprotein E associated with astrocytic glia of the central nervous system and with nonmyelinating glia of the peripheral nervous system, J. Clin. Invest. 76, 1501-1513.
54. Murakami, M., Ushio, Y., Morino, Y., Ohta, T., and Matsukado, Y. (1988) Immunohistochemical localization of apolipoprotein E in human glial neoplasms, J. Clin. Invest. 82, 177-188.
55. Zannis, V. I., Zanni, E. E., Makrides, S. C., Kardassis, D., and Aleshkov, S. (1998) Role of apolipoprotein E in Alzheimer's disease, in NATO ASI Series, Life Sciences (Catravas, J. D., Ed.) pp 179-209, Plenum Press, New York.
56. Petit-Turcotte, C., Stohl, S. M., Beffert, U., Cohn, J. S., Aumont, N., Tremblay, M., Dea, D., Yang, L., Poirier, J., and Shachter, N. S. (2001) Apolipoprotein C-I expression in the brain in Alzheimer's disease, Neurobiol. Dis. 8, 953-963.
57. Karathanasis, S. K., Salmon, E., Haddad, I. A., and Zannis, V. I. (1985) Nucleotide and corresponding amino acid sequences of human apoA-I, apoA-II, apoC-I, apoC-II, apoC-III and apoE cDNA clones, in Biochemistry and Biology of Plasma Proteins 11 (Scanu, A. M., and Spector, A. A., Eds.) pp 475-493, Marcel-Dekker, Inc., New York.